Home » Newsletters » BioWorld Science

BioWorld Science

July 11, 1997

View Archived Issues

Chugai reports sydnonimine derivatives for angina

Banyu claims farnesyltransferase inhibitors

New antitumor taxanes from Yakult Honsha

German introduction for Parkinsan

GeneMedicine and UCSF enter into gene therapy collaboration

Sparta's Spartaject busulfan enters phase I

Draxis Health completes acquisition of Merck Frosst radiopharmaceutical division

DuPont Merck and Elan enter alliance for copromotion of Parkinson's disease products

Progression of Epix Medical's diagnostic agent to phase II triggers milestone payment

Virus Research Institute's rotavirus vaccine enters phase II

Interleukin-11 reviewed

Generic etodolac approved by FDA

TEI-A0225: new treatment for restenosis

Cardiovascular effects of psychotropic drugs

Magnesium implicated in death from cardiovascular disease

Immunological effects of HMG-CoA reductase inhibitors in humans

n-3 fatty acids for prevention of restenosis

Natural products for hyperlipidemia

ETA receptor blockade for counteracting effects of angiotensin II

Hematopoiesis-stimulating compounds from SmithKine Beecham and Nycomed

SmithKline Beecham describes LTB4 antagonists for psoriasis

Factor Xa inhibitors from Berlex

Paclitaxel derivatives developed at Bristol-Myers Squibb

Phase II/III results for Seroquel

In vitro activity of novel pneumocandin antifungal agent

ReoPro effective in baboon models of human renal disorders

HIV-IG pharmacokinetics assessed in AIDS patients

Pharmacokinetic, drug interaction and clinical results with ziprasidone

Once-daily extended-release venlafaxine evaluated in depression

Roberts seeks European approval of Agrylin

Novavax's Estrasorb reduces hot flashes by up to 98% in postmenopausal women

ALRT reports clinical trial status of Panretin

Cel-Sci developing AIDS vaccine with broad activity

Antithrombotic efficacy of TAK-029 in animal models

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...